This question integrates all benefits and harms concerning mortality, morbidity, QoL and further patient relevant outcomes, also considering the amount of false positive and false negative test results. There is no common quantitative summary measure, and even qualitatively a balanced and meaningful presentation is difficult to reach.
The integration of information across domains into the benefit-harm-balance is essential. This issue provides input for ETH (F0010) andECO (E0005) to calculate the incremental effectiveness of the new technology. Information from SAF is needed for this issue: all harms to the patient are listed in outcomes and units which are comparable to the outcomes in EFF domain representing benefits.
Trials, observational studies, modelling studies
A0007, A0011, C0001, C0003, C0004, C0005, C0006, C0007, C0061, E0005, F0001, F0011
A0007, A0011, C0001, C0003, C0004, C0005, C0006, C0007, C0061,